• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips Healthcare’s Q1 operating profits plunge

Philips Healthcare’s Q1 operating profits plunge

April 28, 2015 By MassDevice Contributors Network

Philips Healthcare's Q1 operating profits plunge

(Reuters) — Royal Philips (NYSE:PHG) reported 1st-quarter earnings showing continued weakness in the healthcare equipment operations that are increasingly vital for the Dutch group as it prepares to spin off its lighting operations.

The maker of consumer goods like shavers, toothbrushes and coffee makers as well as healthcare equipment such as CT scanners and patient monitoring systems said operating profit in healthcare fell -84.4% to €17 million ($18 million) from €109 million in the same period in 2014.

Philips blamed the fall on a mix of restructuring charges and higher investment in the unit, which delivered 43% of group revenue in 2014 but suffered from a lengthy production shutdown in the U.S. last year.

The company said today that healthcare sales grew 1% in the 1st quarter of 2015, while order intake "showed low single-digit growth." CEO Frans Van Houten said U.S. production would only be back at full capacity toward the end of 2015.

“The U.S. economy is growing, but in the markets in which we participate, let’s say healthcare, we see a more flattish outlook," Van Houten told reporters.

He also said an "enormous slowdown" in the Chinese healthcare market was continuing, though those negatives were offset by improving order intake in western Europe, Africa and India.

Barclays analyst David Vos said U.S. market share lost to competitors GE (NYSE:GE) and Siemens (NYSE:SI) "will be costly to regain or could be lost altogether."

He said Barclays, which cut its rating on Philips to "underweight" from "equal weight", is also concerned the Chinese government has begun a concerted effort to push Philips and Siemens aside in favor of domestic competitors.

Philips shares, which had risen on Monday to their highest in more than a year, fell 3.4% by 0839 GMT. The stock has underperformed the Dutch AEX index of blue chips by about 10% over the past year.

Group earnings before interest, taxes and amortisation rose 7.6% to €327 million, in line with an average forecast of €324 million from analysts polled by Reuters.

Comparable sales rose 2% to €5.3 billion, thanks to growth in western Europe and some emerging markets.

Both the company’s lighting division and its consumer products division increased operating earnings and the company forecast a "modest" increase in company-wide comparable sales for the full year.

With Philips’ EBITA margin at 6.1% of sales in the quarter, Van Houten repeated a January warning that the EBITA margin in 2016 will be closer to 10% than the 11% Philips is targeting.

Philips is planning to sell its lighting division, the world’s largest lighting maker, via a stock market flotation in the 1st half of 2016.

($1 = 0.9195 euro)

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2015, Philips, Q1

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy